Liver Abnormalities in Cardiac Diseases and Heart Failure

被引:164
作者
Alvarez, Alicia M. [1 ]
Mukherjee, Debabrata [1 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, El Paso, TX 79905 USA
关键词
Heart failure; liver dysfunction; cardiovascular disease; pulsatile liver; hepatic congestion; shock liver; cardiac output;
D O I
10.1055/s-0031-1284434
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Heart failure (HF) is characterized by the inability of systemic perfusion to meet the body's metabolic demands and is usually caused by cardiac pump dysfunction and may occasionally present with symptoms of a noncardiac disorder such as hepatic dysfunction. The primary pathophysiology involved in hepatic dysfunction from HF is either passive congestion from increased filling pressures or low cardiac output and the consequences of impaired perfusion. Passive hepatic congestion due to increased central venous pressure may cause elevations of liver enzymes and both direct and indirect serum bilirubin. Impaired perfusion from decreased cardiac output may be associated with acute hepatocellular necrosis with marked elevations in serum aminotransferases. Cardiogenic ischemic hepatitis ("shock liver'') may ensue following an episode of profound hypotension in patients with acute HF. We discuss pathophysiology and identification of liver abnormalities that are commonly seen in patients with HF.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 44 条
[1]   Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program [J].
Allen, Larry A. ;
Felker, G. Michael ;
Pocock, Stuart ;
McMurray, John J. V. ;
Pfeffer, Marc A. ;
Swedberg, Karl ;
Wang, Duolao ;
Yusuf, Salim ;
Michelson, Eric L. ;
Granger, Christopher B. .
EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (02) :170-177
[2]   CONSTRICTIVE PERICARDITIS MASQUERADING AS BUDD-CHIARI SYNDROME [J].
ARORA, A ;
TANDON, N ;
SHARMA, MP ;
ACHARYA, SK .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1991, 13 (02) :178-181
[3]  
BIRGENS HS, 1978, ACTA MED SCAND, V204, P417
[4]   Pharmacokinetics of valsartan in patients with liver disease [J].
Brookman, LJ ;
Rolan, PE ;
Benjamin, IS ;
Palmer, KR ;
Wyld, PJ ;
Lloyd, P ;
Flesch, G ;
Waldmeier, F ;
Sioufi, A ;
Mullins, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (03) :272-278
[5]   PHARMACOKINETICS OF ESMOLOL IN HEPATIC-DISEASE [J].
BUCHI, KN ;
ROLLINS, DE ;
TOLMAN, KG ;
ACHARI, R ;
DRISSEL, D ;
HULSE, JD .
JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (11) :880-884
[6]   Liver and cardiac function in the long term after Fontan operation [J].
Camposilvan, Sonia ;
Milanesi, Ornella ;
Stellin, Giovanni ;
Pettenazzo, Andrea ;
Zancan, Lucia ;
D'Antiga, Lorenzo .
ANNALS OF THORACIC SURGERY, 2008, 86 (01) :177-182
[7]   SERUM LACTIC-DEHYDROGENASE IN THE DIFFERENTIAL-DIAGNOSIS OF ACUTE HEPATOCELLULAR INJURY [J].
CASSIDY, WM ;
REYNOLDS, TB .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1994, 19 (02) :118-121
[8]  
CLARKE WTW, 1950, AM J PATHOL, V26, P249
[9]   EFFECTS OF CAPTOPRIL ON RENAL-FUNCTION IN PATIENTS WITH CIRRHOSIS AND ASCITES [J].
DASKALOPOULOS, G ;
PINZANI, M ;
MURRAY, N ;
HIRSCHBERG, R ;
ZIPSER, RD .
JOURNAL OF HEPATOLOGY, 1987, 4 (03) :330-336
[10]   Acute hypoxic hepatitis ('liver shock'): still a frequently overlooked cardiological diagnosis [J].
Denis, C ;
de Kerguennec, C ;
Bernuau, J ;
Beauvais, F ;
Solal, AC .
EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (05) :561-565